10437 related articles for article (PubMed ID: 15461355)
1. Inactivation mechanism of tyrosinase in mouse melanoma.
Tomita Y; Seiji M
J Dermatol; 1977 Dec; 4(6):245-9. PubMed ID: 15461355
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of tyrosinase by dopa.
Tomita Y; Hariu A; Mizuno C; Seiji M
J Invest Dermatol; 1980 Nov; 75(5):379-82. PubMed ID: 6776205
[TBL] [Abstract][Full Text] [Related]
3. Nature of tyrosinase inactivation in melanosomes.
Seiji M; Sasaki M; Tomita Y
Tohoku J Exp Med; 1978 Jul; 125(3):233-45. PubMed ID: 211676
[TBL] [Abstract][Full Text] [Related]
4. Melanin formation in the inner ear is catalyzed by a new tyrosine hydroxylase kinetically and structurally different from tyrosinase.
Benedito E; Jiménez-Cervantes C; Pérez D; Cubillana JD; Solano F; Jiménez-Cervantes J; Meyer zum Gottesberge AM; Lozano JA; García-Borrón JC
Biochim Biophys Acta; 1997 Jul; 1336(1):59-72. PubMed ID: 9271251
[TBL] [Abstract][Full Text] [Related]
5. Activation of tyrosinase reduces the cytotoxic effects of the superoxide anion in B16 mouse melanoma cells.
Valverde P; Manning P; McNeil CJ; Thody AJ
Pigment Cell Res; 1996 Apr; 9(2):77-84. PubMed ID: 8857670
[TBL] [Abstract][Full Text] [Related]
6. Ascorbic acid increases the activity and synthesis of tyrosinase in B16F10 cells through activation of p38 mitogen-activated protein kinase.
Lee SA; Son YO; Kook SH; Choi KC; Lee JC
Arch Dermatol Res; 2011 Nov; 303(9):669-78. PubMed ID: 21667118
[TBL] [Abstract][Full Text] [Related]
7. Incorporation and binding of estrogens into melanin: comparison of mushroom and mammalian tyrosinases.
Jacobsohn GM; Jacobsohn MK
Biochim Biophys Acta; 1992 Apr; 1116(2):173-82. PubMed ID: 1316167
[TBL] [Abstract][Full Text] [Related]
8. Singlet oxygen generation during the oxidation of L-tyrosine and L-dopa with mushroom tyrosinase.
Miyaji A; Kohno M; Inoue Y; Baba T
Biochem Biophys Res Commun; 2016 Mar; 471(4):450-3. PubMed ID: 26898801
[TBL] [Abstract][Full Text] [Related]
9. DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis.
Chawla S; Kvalnes K; deLong MA; Wickett R; Manga P; Boissy RE
J Drugs Dermatol; 2012 Oct; 11(10):e28-34. PubMed ID: 23134995
[TBL] [Abstract][Full Text] [Related]
10. Radical production during tyrosinase reaction, dopa-melanin formation, and photoirradiation of dopa-melanin.
Tomita Y; Hariu A; Kato C; Seiji M
J Invest Dermatol; 1984 Jun; 82(6):573-6. PubMed ID: 6327830
[TBL] [Abstract][Full Text] [Related]
11. The effect of catalase on the inactivation of tyrosinase by ascorbic acid and by cysteine or glutathione.
Lindbladh C; Rorsman H; Rosengren E
Acta Derm Venereol; 1983; 63(3):209-14. PubMed ID: 6192633
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of melanogenesis by BMY-28565, a novel compound depressing tyrosinase activity in B16 melanoma cells.
Terao M; Tomita K; Oki T; Tabe L; Gianni M; Garattini E
Biochem Pharmacol; 1992 Jan; 43(2):183-9. PubMed ID: 1739407
[TBL] [Abstract][Full Text] [Related]
13. Ethyl acetate extract from Panax ginseng C.A. Meyer and its main constituents inhibit α-melanocyte-stimulating hormone-induced melanogenesis by suppressing oxidative stress in B16 mouse melanoma cells.
Jiang R; Xu XH; Wang K; Yang XZ; Bi YF; Yan Y; Liu JZ; Chen XN; Wang ZZ; Guo XL; Zhao DQ; Sun LW
J Ethnopharmacol; 2017 Aug; 208():149-156. PubMed ID: 28689798
[TBL] [Abstract][Full Text] [Related]
14. Formation of melanin-tyrosinase complex and its possible significance as a model for control of melanin synthesis.
Menon IA; Haberman HF
Acta Derm Venereol; 1978; 58(1):9-11. PubMed ID: 75646
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the final phase of mammalian melanogenesis. The role of dopachrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole.
Aroca P; Solano F; Salinas C; García-Borrón JC; Lozano JA
Eur J Biochem; 1992 Aug; 208(1):155-63. PubMed ID: 1511683
[TBL] [Abstract][Full Text] [Related]
16. Preparation of purified tyrosinase devoid of dopachrome tautomerase from mammalian malignant melanocytes.
Valverde P; Jiménez-Cervantes C; Salinas C; García-Borrón JC; Solano F; Lozano JA
Pigment Cell Res; 1993 Jun; 6(3):158-64. PubMed ID: 8234201
[TBL] [Abstract][Full Text] [Related]
17. Melanocyte stimulating hormone activation of tyrosinase in B16 mouse melanoma cells. Evidence for a differential induction of two distinct isoenzymes.
Valverde P; García-Borrón JC; Martínez-Liarte JH; Solano F; Lozano JA
FEBS Lett; 1992 Jun; 304(2-3):114-8. PubMed ID: 1352258
[TBL] [Abstract][Full Text] [Related]
18. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase.
Tsukamoto K; Jackson IJ; Urabe K; Montague PM; Hearing VJ
EMBO J; 1992 Feb; 11(2):519-26. PubMed ID: 1537333
[TBL] [Abstract][Full Text] [Related]
19. In vitro melanogenesis inhibitory effects of N-feruloyldopamine.
Leoty-Okombi S; Bonnet S; Rival D; Degrave V; Lin X; Vogelgesang B; André-Frei V
J Cosmet Sci; 2013; 64(2):133-44. PubMed ID: 23578836
[TBL] [Abstract][Full Text] [Related]
20. Mammalian tyrosinase. A comparison of tyrosine hydroxylation and melanin formation.
Hearing VJ; Ekel TM
Biochem J; 1976 Sep; 157(3):549-57. PubMed ID: 825109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
